Australian healthcare stocks on track to end 2023 higher

Ramsay Health Care

28/12/2023 23:22

** Australian healthcare stocks  .AXHJ  on track to end the
year 2.4% higher, recovering from a 8.4% fall in 2022 
    ** Sub-index set to underperform compared to the broader
benchmark index  .AXJO , which is up 8.2% YTD 
    ** Aussie healthcare companies depend on exports to the
United States; volatility in FX market, with the dollar  =USD 
weakening this year, has impacted profitability in 2023 
    ** AXHJ helped by near 216% surge in Neuren Pharmaceuticals
 NEU.AX  and a 74.6% jump in Pro Medicus  PME.AX  - among the
top gainers in healthcare stocks this year 
    ** Neuren eyes its best year since 2013, on its Rett
syndrome drug Daybue picking up sales, among others 
    ** Pro Medicus set for its best year since 2021 on better
results and strategic contracts 
    ** Cochlear  COH.AX  set to end the year 47.2% higher, their
best year since 2005   
    ** Biotech giant and country's priciest stock CSL  CSL.AX 
is set to end marginally lower for the year 
    ** Ramsay Health Care  RHC.AX  fell 19.2% this year, its
worst year since 2002
    ** Healius  HLS.AX  set to decline nearly 43% for the year,
its biggest yearly pct fall since 2015 
    

    <^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Australian Healthcare Stocks    https://tmsnrt.rs/48AfvoY
    ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
 (Reporting by Neha Soni and John Biju in Bengaluru)
 ((Neha.Soni@thomsonreuters.com))